Showing 61-70 of 197 results for "".
DermWireTV: Latest on Galderma, Eczema Awareness, Hacking Derm, and More
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-latest-on-galderma-eczema-awareness-hacking-derm-and-more/19675/In this week’s edition: Galderma’s Aklief (trifarotene) topical cream is now approved for acne. Sandra Johnson, MD weighs in. Supported by Sanofi and Regeneron in partnership with the National Eczema Association, the Understand AD Squad includes dermatologist Mercedes Gonzalez, MD, who discusses herDermwireTV: Rinvoq Approved for Pediatric Psoriatic Arthritis; J&J Acquires Novel AD Candidate
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-rinvoq-approved-for-pediatric-psoriatic-arthritis/26269/In this week's DermwireTV, the FDA approves Rinvoq for pediatric psoriatic arthritis; Johnson & Johnson acquires an AD candidate for $1.25 billion; and the president of Acclaro Medical discusses the latest FDA clearance of its Ultraclear Laser.Ortho Dermatologics NDA, J&J Innovation, Consumer Credit Insights
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-ortho-dermatologics-nda-j-j-innovation-consumer-credit-insights/18395/Two-thirds of prospective patients say they would be more likely to book a procedure if they were aware of financing options. More than three-quarters of prospective patients are unaware of financing options, according to a recent survey by Zalea. In conjunction with Johnson & Johnson Consumer,Experts React to Latest Benzene Analysis
https://practicaldermatology.com/videos/dermwire-tv/experts-react-to-latest-benzene-analysis/29810/In this week's DermwireTV, Practical Dermatology Editorial Board members provide their thoughts on the recent analysis examining benzene concentrations in BPO products; Johnson & Johnson seeks new indications for IL-23 inhibitor Tremfya; and the founder and CEO of Terns discusses plans to improvDermwireTV: J&J Boosts Dermatology Pipeline; New Humira Biosimilar Launched
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-jj-boosts-dermatology-pipeline-new-humira-biosimilar-launched/24561/In this episode of DermwireTV, Johnson & Johnson makes a major acquisition to expand its dermatology treatment pipeline; the first high-concentration, citrate-free biosimilar to Humira is launched in the US; and in the C-Suite Chats feature, the CEO of Benev discusses the medical aesthetic markeRecent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/23510/Clinical Insights on Management of Comorbidities in the Psoriasis Patient
https://practicaldermatology.com/topics/psoriasis/clinical-insights-on-management-of-comorbidities-in-the-psoriasis-patient/21375/As psoriasis is associated with an increasing number of comorbidities, clinicians discuss their approach to management focused on the whole patient.Creating An Enjoyable Experience
https://practicaldermatology.com/topics/practice-management/creating-an-enjoyable-experience/20732/How to establish a healthy practice culture that satisfies staff.Special Report: Dermatology Industry Responds to Inequities in Care
https://practicaldermatology.com/topics/skin-of-color/special-report-dermatology-industry-responds-to-inequities-in-care/23765/Sublative Radiofrequency Improves Skin Texture and Improves Dry Eyes
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/sublative-radiofrequency-improves-skin-texture-and-improves-dry-eyes/22075/A popular aesthetic treatment may have an added benefit when used in the periocular area.